- Our model results show that farmers’ test adoption decisions are strongly dependent on whether they consider themselves at high risk- , medium risk-, or low risk of infestation with sheep scab (see section 5 for a definition of the risk states). The more at risk of infestation a farmer considers his flock, the more likely he is to adopt the new test.
- For biologically realistic parameters and an expected test cost of around 50% more than the current clinical diagnosis via skin scraping, our model predicts that farmers at high risk of infestation will always adopt the new ELISA blood test. By contrast, the model predicts no uptake of the test for farmers believing their flock is at low risk of infestation. If a farmer considers his flock at medium risk, whether they adopt the test or not is decided by their preference for shortterm over long-term benefits. These results are shown in Figure 1 (blue triangles).
- The uptake of the test should reduce the proportion of infected farms by 50% or more but the financial benefits for the farmers are not substantial.
- Farmers make decisions about adopting the test not only on the cost of the new diagnostic test but also by their preference between short term vs long term benefits. Key to the decision is to weigh up:
- immediate costs and benefits of adopting the test (may not pay off in the current year if test costs are high)
- long-term benefits of moving to a lower risk state, should neighbouring farmers adopt the test. For example, if a farmer at medium risk values immediate returns only, he will not adopt the test this season, particularly if the test becomes very expensive or unlikely to be subsidised by the Government. However, a farmer in the medium risk state who does consider long term benefits will adopt the test.
- Test adoption decisions when farmers acted in their own self-interest only (see Fig. 1 blue triangles) resulted most of the time in the best outcome for both farmers in terms of their combined profits (red triangles in Fig. 1).
- Test adoption decisions are relatively robust to the cost of the test, with substantial increases or decreases in test cost required to change the overall pattern of test adoption. The test costs would need to more than double before test adoption is not always observed in the high-risk state, and would need to become very low before test adoption can be seen in the low-risk state.